Melissa Davis

Senior Writer

Prior to joining TheStreet.com, Davis worked two years for the Daily Oklahoman, winning the state's top honors for both investigative and business reporting. Before that, she spent two years as managing editor of Durocher's Oklahoma City Business, a local business journal. She has a master's degree in mass communications from the University of Oklahoma and more than 15 years of writing and editing experience.

Melissa Davis
By This Author:
« Back
Page 1 of 148
Article

Arthrocare Gets No Medicare Love

By Melissa Davis

A ruling by regulators may put sales of the company's spinal device in jeopardy.

Related Topics: Health Care

12:13PM 10/02/08

Article

Walgreen Wades into Antitrust Waters

By Melissa Davis

The company sees Hawaii as a key market.

Related Topics: Retail

04:56PM 09/30/08

Article

Walgreen Feels Margin Pain

By Melissa Davis

The company boosts profit by 12%, but it comes at a price.

Related Topics: Retail

02:06PM 09/29/08

Article

Longs Sticking to CVS Merger Plan

By Melissa Davis

But shareholders keep wanting a more serious look at Walgreen's higher bid.

Related Topics: Health Care | M&A

04:21PM 09/17/08

Article

HMA's CEO Takes a Hike

By Melissa Davis

After a year on the job, Burke Whitman sees military service as the better option.

Related Topics: Health Care

02:23PM 09/15/08

Article

CVS Angles for Longs' Real Estate Bounty

By Melissa Davis

Shareholders say the buyout target has undervalued its real estate portfolio -- the real prize of any merger.

Related Topics: M&A | Retail

01:20PM 09/15/08

Article

Longs Drugs CEO Set for Fat Merger Payday

By Melissa Davis

Warren Bryant could snag up to $23 million, if CVS' buyout goes through. But some shareholders want a better deal.

Related Topics: M&A | Retail

12:52PM 09/15/08

Article

Arthrocare Device Use Draws More Scrutiny

By Melissa Davis

A mounting FBI probe is looking into surgeries requiring one of the company's products.

Related Topics: Health Care

02:22PM 08/28/08

Article

Amedisys' CFO Carousel Misses the Mark

By Melissa Davis

The company can't seem to keep a financial chief. Maybe the problem is higher up?

Related Topics: Health Care

02:02PM 08/27/08

Article

Schering Regroups After FDA Rejection

By Melissa Davis

The company plans to rely on the sales of other drugs, particularly in overseas markets.

Related Topics: Health Care

05:38PM 08/13/08

« Back
Page 1 of 148
Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Sign up for our FREE newsletters now. See All

  • Cramer's Daily Booyah!
  • Before the Bell

Premium Stock Ideas